Bladder Cancer Advocacy Network shared a post on X:
“What do 1,100 bladder cancer patients say about diagnosis, care and survivorship?
A new national report from BCAN shares what patients experienced and where improvements are needed.
Thanks to report sponsors Ferring Uro-Oncology U.S., Johnson and Johnson, UroGen Pharma.”
Petros Grivas, Clinical Director of the GU Cancer Program at the University of Washington shared this post, adding:
“Thanks Bladder Cancer Advocacy Network for your amazing work on advocacy, education, research, community support!
We are all united/aligned to support patients and families”
Other articles about bladder cancer on OncoDaily.